Consistent with prior studies demonstrating that increased intratumoral invariant NKT-cells are associated with HCC suppression, improved patient survival, and less tumor recurrence [32–34], the exosome-treated rats harbored significantly smaller tumors and more intratumoral invariant (CD8α+) NKT-cells and low-grade HCC than the controls. This evidence concerns the gene CD8A and neoplasm.